Home » Topics » Regulatory » Patents

Patents
RSS

Substance P antagonists from Pfizer especially useful for pain, inflammation

April 28, 1998

Anti-MRSA carbapenems developed at Suntory

April 28, 1998

Lilly presents naphthalene and related compounds for postmenopausal therapy

April 28, 1998

Toagosei presents several related antitumor series

April 28, 1998

Gastric prokinetic/antiemetic agents from Dainippon

April 28, 1998

Toyama focuses on cephalosporins, particularly anti-MRSA compounds

April 27, 1998

Cathepsin inhibitors under study at Nippon Chemiphar

April 27, 1998

Baccatin derivatives with antitumor activity developed at Tanabe Seiyaku

April 27, 1998

Bronchodilating and antiinflammatory agents claimed by Nikken

April 27, 1998

Nitroquinoxalinediones for inhibiting neuronal cell death

April 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.